BPI Technologies Corporation, a recognized leader in revenue recognition, offers innovative software solutions to help the pharmaceutical, bio-tech and med-device industries make faster, smarter, better-informed business decisions, and maximize profit. We are a forward-looking company and believe in investing in a vision of today that can become a reality tomorrow. Transformation of Gross-to-Net processes is one such area of expertise. From business models to technology, BPI’s gross-to-net solution is helping companies achieve end-to-end transformation of GTN across all channels of their business. Key to transformation is the flexibility and scalability to configure our application to address the ever-changing complexity of the commercial and regulatory environments.
BPI and Model N have partnered to provide customers seamless integration that combines comprehensive structural and transactional data across commercial, government, and chargeback channels from Model N with a sophisticated gross-to-net (GTN) revenue recognition offering from BPI. Together, the Model N BPI Gross-to-Net solution will provide customers with fast and complete visibility into pre-deal analysis, the true price of products, true net revenue, accurate accruals, full audit reporting, and reliable forecasts that are critical to pharmaceutical and medical technology manufacturers.
To learn more about BPI Technologies, click here.
